Skip to content

Effects of antioxidants supplementation on the quality of life

Effects of antioxidants supplementation on the quality of life - Effects of antioxidants supplementation on the quality of life

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020995
Enrollment
76
Registered
2017-12-19
Start date
2016-02-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Period:8 weeks Supplementation:Antioxidants Period:8 weeks Supplementation:Placebo

Sponsors

Oneness support Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Healthy Japanese subjects aged from 40 to 69 years old 2.Subjects who are office workers. 3.Subjects who feel tired or low in vitality. 4.Subjects who have the 'Vitality' scores lower than 62.8(the national standard value) in SF-36 v2 (the questionnaire of the health related QOL) .

Exclusion criteria

Exclusion criteria: 1.Subjects who have the history of diabetes, liver disease, kidney disease, heart disease, respiratory disease, chronic fatigue syndrome, or other severe diseases 2.Subjects who have had the surgery of the digestive tract. 3.Subjects who have the disease under treatment. 4.Subjects who have food or chemical allergies. 5.Smoker. 6.Subjects who regularly use health food, supplements, medicines (for example, statins, anti-hypertensive agents, hypoglycemic agents, or warfarine) or have used them within 1 month. 7.Subjects who drink excessive alcohol, or who can not stop drinking alcohol for the test day and the day before the test day. 8.Subjects who have been suffering from anemia. 9.Subjects who plays heavyexercise or who are on a diet restriction. 10.Subjects who is pregnant or breastfeeding 11.Subjects who take part in another clinical study during the study. 12.Subjects whose BMI are less than 18.5 or over 25.0. 13.Subjects whose clinical test value, blood pressure, pulse rate are markedly over or below the standard value. 14.Subjects deemed unsuitable by the investigator for other reasons

Design outcomes

Primary

MeasureTime frame
The 'Vitality' scores in the questionnaire of health related QOL.

Countries

Japan

Contacts

Public ContactMakoto Terashima

Oneness support Co., Ltd. Clinical trial Division

shiken@oneness-sup.co.jp06-4801-8917

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026